Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Incorporating Alcohol Pharmacotherapies Into Medical Practice
Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy.
Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy.
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.
Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.
ARESTIN®
Long term safety and efficacy study of teriflunomide 7 mg or 14 mg in patients with relapsing-remitting multiple sclerosis
Repurposing drugs for disease modification in multiple sclerosis
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance.
Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a ...
Top ten research priorities for spinal cord injury: the methodology and results of a British priority setting partnership.
Intas launches biosimilar version of Rituximab
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.
Effect of IFN β-1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients.
Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing-Remitting Multiple Sclerosis.
Annualized relapse rate of first-line treatments for multiple sclerosis: a meta-analysis, including indirect comparisons versus fingolimod.
Oracle Cladribine in Early Multiple Sclerisis (MS) (ORACLE MS)
A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA).
Refining diagnosis of multiple sclerosis with revised MRI criteria.
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events.
Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.
Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis.
A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.

Pages